December 31 2023- Company advises they have generated the potency data requested by the FDA. ie we have answered the CRL
February 29 2024- Company advised new potency assay data was with the FDA and a follow up meeting scheduled
March 26th 2024- The FDA responds to the potency data provided , which the company prepared specifically in answer to the CRL.
So the potency data was with the FDA for a month. They checked it to see whether it answered the problems specifically raised in the CRL.
If it didn't answer the CRL then they would have received a negative reply.
Instead the company released a statement saying the FDA NOTIFIES MESOBLAST
THAT AVAILABLE CLINICAL DATA FROM PHASE 3 TRIAL APPEAR SUFFICIENT TO
SUPPORT BLA SUBMISSION FOR REMESTEMCEL-L IN CHILDREN WITH STEROIDREFRACTORY ACUTE GRAFT VERSUS HOST DISEASE (SR-aGVHD)
They don't say the potency data is sufficient- but they may as well have. We are not being told to proceed because the data is crap, rather- spectacularly- it answers the CRL.
This stock is now about dollars not cents.
Safety/Efficacy/Manufacturing and now presumably potency is done and dusted.
The company has never been in a better position
ever
Reg
- Forums
- ASX - By Stock
- MSB
- 2024 Here we go again.
2024 Here we go again., page-386
-
- There are more pages in this discussion • 558 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 73626 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10033 | 1.485 |
4 | 53700 | 1.480 |
1 | 770 | 1.475 |
3 | 62048 | 1.460 |
1 | 50000 | 1.455 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 21995 | 1 |
1.505 | 24000 | 1 |
1.510 | 13666 | 2 |
1.515 | 99798 | 1 |
1.520 | 27250 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
MSB (ASX) Chart |